https://doi.org/10.4081/monaldi.2023.2667
Differences in nutritional status of patients with chronic obstructive pulmonary disease between Mediterranean and non-Mediterranean regions in Croatia
Submitted: June 16, 2023
Accepted: August 29, 2023
Published: September 13, 2023
Accepted: August 29, 2023
Abstract Views: 775
PDF: 86
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
The nutritional status of patients with chronic obstructive pulmonary disease (COPD) is a significant factor that influences the prognosis of the disease. This observational study aimed to analyze the nutritional status of COPD patients and assess the associations between nutritional status, disease severity, and exercise capacity in four different regions of Croatia. In this multicenter study, 534 COPD patients were recruited and evaluated concerning fat-free mass (FFM), FFM index (FFMI), skeletal muscle mass index (SMMI), phase angle (PhA), pulmonary function tests, and the 6-minute walk test (6MWT). There were 325 (60.9%) male and 209 (39.1%) female patients with a mean age of 66.7±8.4 years. Most patients (73.2%) exhibited a moderate to severely abnormal obstructive pattern and had a reduced 6MWT distance (396.5±110.8 m). Among the participants, 32.8% were overweight and 22.3% were obese, and they had satisfactory values for nutritional status variables (FFM, FFMI, SMMI, PhA). There were no statistical differences between the centers in terms of nutritional status variables. There was a significantly positive correlation of forced expiratory volume in one second with body mass index (BMI) (r=0.148, p=0.001), PhA (r=0.256, p=0.00), FFM (r=0.365, p=0.00), and SMMI (r=0.238, p=0.00). However, there was no significant correlation of the 6MWT with BMI (r=-0.049, p=0.254), FFM (r=0.065, p=0.133), and SMMI (r=-0.007, p=0.867). The data analysis demonstrated that our patients were not underweight and that there was no significant difference between the centers in terms of BMI, FFM, FFMI, SMMI, and PhA. This lack of significant difference was observed even though one of the regions studied was Mediterranean.
Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for prevention, diagnosis and management of COPD: report 2023. Available from: https://goldcopd.org/2023-gold-report-2/ . Accessed on: 6/03/2023.
Halpin DMG, Celli BR, Criner GJ, et al. The GOLD Summit on chronic obstructive pulmonary disease in low- and middle-income countries. Int J Tuberc Lung Dis 2019;23:1131-41.
Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006;3: e442.
Eisner MD, Blanc PD, Sidney S, et al. Body composition and functional limitation in COPD. Respir Res 2007;8:7.
Laviolette L, Sava F, O’Donnell DE, et al. Effect of obesity on constant work rate exercise in hyperinflated men with COPD. BMC Pulm Med 2010;10:33.
O’Donnell DE, Deesomchok A, Lam YM, et al. Effects of BMI on static lung volumes in patients with airway obstruction. Chest 2011;140:461-8.
Vozoris NT, O’Donnell DE. Prevalence, risk factors, activity limitation and health care utilization of an obese, population-based sample with chronic obstructive pulmonary disease. Can Respir J 2012;19:e18-24.
White JV, Guenter P, Jensen G, et al. Consensus statement: Academy of Nutrition and Dietetics and American Society for Parenteral and Enteral Nutrition: characteristics recommended for the identification and documentation of adult malnutrition (undernutrition). JPEN J Parenter Enteral Nutr 2012;36:275-83.
Vestbo J, Prescott E, Almdal T, et al. Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study. Am J Respir Crit Care Med 2006;173:79-83.
Raad S, Smith C, Allen K. Nutrition status and chronic obstructive pulmonary disease: can we move beyond the body mass index? Nutr Clin Pract 2019;34:330-9.
De Blasio F, Scalfi L, Di Gregorio A, et al. Raw bioelectrical impedance analysis variables are independent predictors of early all-cause mortality in patients with COPD. Chest 2019;155:1148-57.
Luo Y, Zhou L, Li Y, et al. Fat-free mass index for evaluating the nutritional status and disease severity in COPD. Respir Care 2016;61:680-8.
Nguyen HT, Collins PF, Pavey TG, et al. Nutritional status, dietary intake, and health-related quality of life in outpatients with COPD. Int J Chron Obstruct Pulmon Dis 2019;14:215-26.
Mete B, Pehlivan E, Gülbaş G, Günen H. Prevalence of malnutrition in COPD and its relationship with the parameters related to disease severity. Int J Chron Obstruct Pulmon Dis 2018;13:3307-12.
Trichopoulou A, Kouris-Blazos A, Wahlqvist ML, et al. Diet and overall survival in elderly people. BMJ 1995;311:1457-60.
Fischer A, Johansson I, Blomberg A, Sundström B. Adherence to a Mediterranean-like diet as a protective factor against COPD: A nested case-control study. COPD 2019;16:272-7.
ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002;166:111-7.
Kyle UG, Bosaeus I, De Lorenzo AD, et al. Bioelectrical impedance analysis-part II: utilization in clinical practice. Clin Nutr 2004;23:1430-53.
NCD Risk Factor Collaboration (NCD-RisC). Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants. Lancet 2016;387:1377-96.
Medanić D, Pucarin-Cvetković J. Obesity--a public health problem and challenge. Acta Medica Croat 2012;66:347-54. [Article in Croatian].
Maslarda D, Bressan L. Eating disorder - obesity: eating habits, physical activity and self-reported BMI in Croatia. J Appl Health Sci 2020;6:83-90. [Article in Croatian].
Bhatta L, Leivseth L, Mai XM et al. GOLD classifications, COPD hospitalization, and all-cause mortality in chronic obstructive pulmonary disease: the HUNT study. Int J Chron Obstruct Pulmon Dis 2020;15:225-33.
Kahnert K, Alter P, Young D, et al. The revised GOLD 2017 COPD categorization in relation to comorbidities. Respir Med 2018;134:79-85.
Le LAK, Johannessen A, Hardie JA, et al. Prevalence and prognostic ability of the GOLD 2017 classification compared to the GOLD 2011 classification in a Norwegian COPD cohort. Int J Chron Obstruct Pulmon Dis 2019;14:1639-55.
Varmaghani M, Dehghani M, Heidari E, et al. Global prevalence of chronic obstructive pulmonary disease: systematic review and meta-analysis. East Mediterr Health J 2019;25:47-57.
Putcha N, Drummond MB, Wise RA, Hansel NN. Comorbidities and chronic obstructive pulmonary disease: prevalence, influence on outcomes, and management. Semin Respir Crit Care Med 2015;36:575-91.
Smith MC, Wrobel JP. Epidemiology and clinical impact of major comorbidities in patients with COPD. Int J Chron Obstruct Pulmon Dis 2014;9:871-88.
Cavaillès A, Brinchault-Rabin G, Dixmier A, et al. Comorbidities of COPD. Eur Respir Rev 2013;22:454-75.
Sabino PG, Silva BM, Brunetto AF. Nutritional status is related to fat-free mass, exercise capacity and inspiratory strength in severe chronic obstructive pulmonary disease patients. Clinics (Sao Paulo) 2010;65:599-605.
James BD, Jones AV, Trethewey RE, Evans RA. Obesity and metabolic syndrome in COPD: is exercise the answer? Chron Respir Dis 2018;15:173-81.
Vrbica Ž, Vukić Dugac A, Popović Grle S, et al. Recommendations for prevention and treatment of malnutrition in patients with chronic obstructive pulmonary disease. Liječnički Vjesnik 2018;140:183-9. [Article in Croatian].
Ethics Approval
The study protocol was approved by the Ethical Review Committee of the University of University Hospital Centre Zagreb (ID 02/18 AG) as well as by the Ethical Committee of the University Hospital Centre Rijeka, the University Hospital Centre Osijek and Zadar General Hospital.How to Cite
Muršić, Davorka, Tajana Jalušić Glunčić, Jelena Ostojić, Sanda Škrinjarić Cincar, Ljiljana Bulat Kardum, Martina Dokoza, Nataša Karamarković Lazarušić, Erim Bešić, Miroslav Samaržija, and Andrea Vukić Dugac. 2023. “Differences in Nutritional Status of Patients With Chronic Obstructive Pulmonary Disease Between Mediterranean and Non-Mediterranean Regions in Croatia”. Monaldi Archives for Chest Disease 94 (3). https://doi.org/10.4081/monaldi.2023.2667.
Copyright (c) 2023 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Similar Articles
- E.M. Clini, P. Siddu, L. Trianni, R. Graziosi, E. Crisafulli, M.T. Nobile, Activity and analysis of costs in a dedicated weaning centre , Monaldi Archives for Chest Disease: Vol. 69 No. 2 (2008): Pulmonary series
- Bruno Balbi, Claudio Marcassa, Fabrizio Pisani, Giacomo Corica, Antonio Spanevello, Integrated care of chronic degenerative non-communicable diseases and rehabilitation: the odd couple? , Monaldi Archives for Chest Disease: Vol. 87 No. 1 (2017)
- Shekhar Kunal, Sudhir Jain, Ashok Shah, Middle lobe syndrome: An exceptional presentation of concomitant lepidic adenocarcinoma and bronchial anthracofibrosis , Monaldi Archives for Chest Disease: Vol. 87 No. 3 (2017)
- Halil Yanardag, Cuneyt Tetikkurt, Muammer Bilir, Clinical and prognostic significance of muscle biopsy in sarcoidosis , Monaldi Archives for Chest Disease: Vol. 88 No. 1 (2018)
- Megha Hegde, Saurav Raj, Aishwarya S Pattanshetti, Sanatkumar Bharamu Nyamagoud, Gaining insights into chronic obstructive pulmonary disease exacerbation through emerging biomarkers and the chronic obstructive pulmonary disease assessment test score , Monaldi Archives for Chest Disease: Early Access
- Gaukhar Kurmanova, Almas Zhanaev, Akzharkyn Kaldybek, Balkiya Abdrakhmanova, Almira Akparova, Impact of the COVID-19 pandemic on the clinical features of patients with chronic obstructive pulmonary disease: an observational cross-sectional study , Monaldi Archives for Chest Disease: Early Access
- T.R.J. Schermer, C.G.J. Saris, W.J.H.M. Van den Bosch, N.H. Chavannes, C.P. Van Schayck, P.N.R. Dekhuijzen, C. Van Weel, Exacerbations and associated healthcare cost in patients with COPD in general practice , Monaldi Archives for Chest Disease: Vol. 65 No. 3 (2006): Pulmonary series
- Matteo Bonini, Paolo Palange, Roflumilast is safe and effective in improving symptoms and lung function in severe COPD , Monaldi Archives for Chest Disease: Vol. 79 No. 3-4 (2013): Pulmonary series - Supplement 1
- E. Pozzi, Acebrophylline: an airway mucoregulator and anti-inflammatory agent , Monaldi Archives for Chest Disease: Vol. 67 No. 2 (2007): Pulmonary series
- L. Moroni, O. Bettinardi, G. Vidotto, G. Balestroni, G. Bruletti, I. Giorgi, G. Bertolotti, Anxiety and Depression Short Scale: norms for its use in rehabilitation , Monaldi Archives for Chest Disease: Vol. 66 No. 4 (2006): Cardiac series
<< < 4 5 6 7 8 9 10 11 12 13 > >>
You may also start an advanced similarity search for this article.
